Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy.

Jasmin, Jean-François

Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy. [electronic resource] - Circulation Aug 2006 - 912-20 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1524-4539

10.1161/CIRCULATIONAHA.106.634709 doi


Amino Acid Sequence
Animals
Biotinylation
Caveolin 1--administration & dosage
Cell Membrane Permeability
Disease Models, Animal
Hypertension, Pulmonary--chemically induced
Hypertrophy, Right Ventricular--chemically induced
Male
Molecular Sequence Data
Monocrotaline--toxicity
Peptide Fragments--therapeutic use
Rats
Rats, Sprague-Dawley